期刊
BIOLOGIA
卷 76, 期 5, 页码 1535-1550出版社
SPRINGER
DOI: 10.1007/s11756-021-00697-x
关键词
Antibiotic resistance; ESKAPE pathogens; Horizontal gene transfer; Antibiotic stewardship
类别
资金
- Ball State University (BSU) Department of Biology
- BSU ASPiRE internal grants program
Antibiotic resistance is a major global challenge in modern medicine and society, causing over 700,000 deaths annually. Solutions to this crisis require not only the development of novel compounds, but also significant changes in healthcare and consumer practices.
Antibiotic resistance is one of the greatest worldwide challenges to modern medicine, and society at large, and one of the least appreciated by practitioners and the lay community. Many strains of multi-drug resistant bacteria such as methicillin and vancomycin-resistant Staphylococcus aureus and multi-drug resistant Mycobacterium tuberculosis continue to plague both developed and underdeveloped countries alike. Collectively over 700,000 deaths occur annually as a consequence of infections from antibiotic-resistant bacteria. Presently, many scientists and clinicians seek to find solutions to this ever-growing crisis. Today, the most common causes of hospital-acquired and multi-drug resistant infections are the ESKAPE group of bacteria (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.), six genera and species with a host of mechanisms to survive against even extremely potent antibiotics. Limited research currently focuses on discovering or developing novel compounds that will hopefully turn the tide and tackle the problem of resistance, but significant changes in healthcare and consumer practices will be necessary as well, to successfully address this dilemma. This review provides a status report on a rather silent global crisis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据